eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR was delisted on the 2nd of July, 2024.
0 hedge funds and large institutions have $0 invested in eFFECTOR Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $4.33K → $0 (-$4.33K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.29K |
| 2 |
Blackstone Inc
New York
|
-$2.04K |
| 3 |
Barclays
London,
United Kingdom
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| – | -$2.29K | -61,758 | Closed |
|
|
2
Blackstone Inc
New York
| – | -$2.04K | -52,343 | Closed |
|
|
3
Barclays
London,
United Kingdom
| – | -$4 | -100 | Closed |
|
EFTR Hedge Fund Activity: Q4 2024 in Review
0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Common Stock (EFTR) for Q4 2024, worth a combined $0 — down 100% from $4.33K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of EFTR and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, exiting entirely with an estimated $2.29K sold.
- 0 institutional investors held eFFECTOR Therapeutics, Inc. Common Stock (EFTR) as of Q4 2024, down from 3 in Q3 2024.
- Funds reported $0 of eFFECTOR Therapeutics, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
- 0 funds opened new eFFECTOR Therapeutics, Inc. Common Stock positions in Q4 2024 and 3 closed out, a net change of -3 holders.
- The largest eFFECTOR Therapeutics, Inc. Common Stock seller in Q4 2024 was Sabby Management, an estimated $2.29K sold.
Based on aggregated 13F filings for Q4 2024.